EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Harvard Apparatus Regenerative Technology, Inc. (HRGN) had EBIT Margin of -982.24% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.70M |
|
$-6.87M |
|
$0.65M |
|
$0.06M |
|
$7.62M |
|
$-6.92M |
|
$0.05M |
|
$-6.87M |
|
$-6.87M |
|
$-6.87M |
|
$-6.87M |
|
$-6.87M |
|
$-6.87M |
|
$-6.92M |
|
$-6.81M |
|
16.52M |
|
16.52M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$1.83M |
|
$0.01M |
|
$0.85M |
|
$2.68M |
|
$1.53M |
|
-- |
|
$0.09M |
|
$1.62M |
|
$1.06M |
|
$1.06M |
|
$1.06M |
|
17.58M |
|
| Cash Flow Statement Financials | |
$-3.83M |
|
-- |
|
$2.70M |
|
$2.49M |
|
$1.35M |
|
$-1.13M |
|
$2.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
8.24% |
|
-982.24% |
|
|
EBIT Margin |
-982.24% |
-967.61% |
|
-975.71% |
|
-975.71% |
|
$-3.83M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
40.38 |
|
44.00 |
|
8.30 |
|
-649.86% |
|
-649.86% |
|
-256.59% |
|
-649.86% |
|
$0.06 |
|
$-0.23 |
|
$-0.23 |
|